|
Volumn 34, Issue 8, 2002, Pages 3347-3348
|
Future trends in clinical islet transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
DACLIZUMAB;
GLUCOCORTICOID;
INSULIN;
LYMPHOCYTE ANTIBODY;
RAPAMYCIN;
TACROLIMUS;
ALLOGRAFT;
ARTICLE;
BONE MARROW TRANSPLANTATION;
CELL ISOLATION;
CRYOPRESERVATION;
DIABETIC COMA;
DIABETIC KETOACIDOSIS;
DISEASE COURSE;
EMBRYONIC STRUCTURES;
FETAL CALF SERUM;
GENE THERAPY;
GENETIC ENGINEERING;
GRAFT REJECTION;
HUMAN;
HYPOGLYCEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN TREATMENT;
ISCHEMIA;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
KILLER CELL;
LIVER CELL;
MORBIDITY;
PANCREAS ISLET;
PANCREAS ISLET TRANSPLANTATION;
PRIORITY JOURNAL;
SHEEP;
SIDE EFFECT;
SKIN;
STEM CELL;
STEM CELL TRANSPLANTATION;
SWINE;
TRANSGENIC ANIMAL;
TREATMENT OUTCOME;
VIRUS TRANSMISSION;
XENOTRANSPLANTATION;
ZOONOSIS;
PANCREAS TRANSPLANTATION;
DIABETES MELLITUS, TYPE 1;
HUMANS;
ISLETS OF LANGERHANS TRANSPLANTATION;
PANCREAS TRANSPLANTATION;
|
EID: 0036903432
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03613-8 Document Type: Article |
Times cited : (21)
|
References (28)
|